A multicentre, double-blind, randomised, parallel group, placebo-controlled trial of LAX-101 (ethyl eicosapentaenoate [EPA]) in patients with a new or recurrent episode of depression

Update Il y a 4 ans
Reference: ISRCTN63565713

Woman and Man

Extract

Not provided at time of registration


Inclusion criteria

  • depression

Links